Top liver disease conference showcases positive clinical data from Yaqrit’s technologies
June 24, 2021 10:03 ET
|
Yaqrit Discovery Ltd
Top liver disease conference showcases positive clinical data from Yaqrit’s technologies Results from two trials presented at EASL1 International Liver Conference 2021 show benefits for patients...
Preliminary results from Carbalive and Dialive trials signal potential for new therapies to treat decompensated cirrhosis and reverse liver failure
January 07, 2021 02:01 ET
|
Yaqrit Discovery Ltd
Preliminary results from Carbalive and Dialive trials signal potential for new therapies to treat decompensated cirrhosis and reverse liver failure Orally-administered, non-absorbable engineered...
Yaqrit as part of the ALIVER Consortium announces completion of first randomised controlled study of DIALIVE for ACLF at EASL’s Digital International Liver Congress
August 27, 2020 03:00 ET
|
Yaqrit Discovery Ltd
Yaqrit as part of the ALIVER Consortium announces completion of first randomised controlled study of DIALIVE for ACLF at EASL’s Digital International Liver Congress Data from study to be...